ConductScience.org, home

Paper37686553

Recurrent Glioblastoma: A Review of the Treatment Options.

Vaz-Salgado MA and 12 others. Cancers (Basel), 2023. Cited by 126 papers, by iCite.

Cite this record

ConductScience Library. Recurrent Glioblastoma: A Review of the Treatment Options. Papers, record 37686553. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37686553

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recurrent Glioblastoma: A Review of the Treatment Options.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
126
iCite
Relative citation ratio, by iCite
14.6
iCite
Revised in PubMed
2023-09-11
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vaz-Salgado MAMaria Angeles
2Villamayor MMaríahttps://orcid.org/0000-0002-7187-5758
3Albarrán VVíctorhttps://orcid.org/0000-0001-6356-2551
4Alía VVíctorhttps://orcid.org/0000-0002-1013-8105
5Sotoca PPilar
6Chamorro JJesús
7Rosero DDiana
8Barrill AMAna M
9Martín MMercedes
10Fernandez EEva
11Gutierrez JAJosé Antonio
12Rojas-Medina LMLuis Mariano
13Ley LLuishttps://orcid.org/0000-0002-4770-8271

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References132

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131122294The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma.J Exp Clin Cancer Res2019https://conductscience.org/library/papers/31122294PubMed
228575464Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.Neuro Oncol2017https://conductscience.org/library/papers/28575464PubMed
334559423Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.Cochrane Database Syst Rev2021https://conductscience.org/library/papers/34559423PubMed
430500939A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.Neuro Oncol2019https://conductscience.org/library/papers/30500939PubMed
532200460Proton therapy re-irradiation preserves health-related quality of life in large recurrent glioblastoma.J Cancer Res Clin Oncol2020https://conductscience.org/library/papers/32200460PubMed
617576523Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients.J Neurooncol2008https://conductscience.org/library/papers/17576523PubMed
722837387Transforming fusions of FGFR and TACC genes in human glioblastoma.Science2012https://conductscience.org/library/papers/22837387PubMed
819720927Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.J Clin Oncol2009https://conductscience.org/library/papers/19720927PubMed
935864254Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.Nat Med2022https://conductscience.org/library/papers/35864254PubMed
1018588890Hypoxia-inducible factor-1alpha regulates matrix metalloproteinase-1 activity in human bone marrow-derived mesenchymal stem cells.FEBS Lett2008https://conductscience.org/library/papers/18588890PubMed
1131747009INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma.Neuro Oncol2020https://conductscience.org/library/papers/31747009PubMed
1233838625Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.N Engl J Med2021https://conductscience.org/library/papers/33838625PubMed
1330266892A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma.Oncologist2019https://conductscience.org/library/papers/30266892PubMed
1428426845HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.JAMA Oncol2017https://conductscience.org/library/papers/28426845PubMed
1524764576Oncolytic viruses and their application to cancer immunotherapy.Cancer Immunol Res2014https://conductscience.org/library/papers/24764576PubMed
1629445288Prognostic significance of epidermal growth factor receptor expression in glioma patients.Onco Targets Ther2018https://conductscience.org/library/papers/29445288PubMed
1731750274Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma.Oncolytic Virother2019https://conductscience.org/library/papers/31750274PubMed
1818525321Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience.Anticancer Drugs2008https://conductscience.org/library/papers/18525321PubMed
1935849035Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.Neuro Oncol2023https://conductscience.org/library/papers/35849035PubMed
2034498213Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation.J Neurooncol2021https://conductscience.org/library/papers/34498213PubMed

See all 132 referencesDownload CSV of references

Cited by104

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.

PMIDTitleJournalYearIn PapersSource
42893563AI-bioinformatics synergy for precision medicine in brain diseases: integrating radiomics and multi-omics data.Brief Bioinform2026https://conductscience.org/library/papers/42893563PubMed
42857743Gallium maltolate causes genomic instability to enhance glioblastoma response to radiation and temozolomide.Neurooncol Adv2026https://conductscience.org/library/papers/42857743PubMed
42852014Reassessing Viral Gene Therapy for Glioblastoma: Translational Opportunities and Challenges.Yale J Biol Med2026https://conductscience.org/library/papers/42852014PubMed
42824982Receptor tyrosine kinase targeted therapies in glioblastoma: a systematic review.Front Med (Lausanne)2026https://conductscience.org/library/papers/42824982PubMed
42724833FET-PET vs. MRI in re-irradiation of recurrent glioblastoma: no added benefit, but key insights for the future.Transl Cancer Res2026https://conductscience.org/library/papers/42724833PubMed
42698902Toward functional precision oncology: organotypic brain slices in glioblastoma.Front Oncol2026https://conductscience.org/library/papers/42698902PubMed
42694176Comparative efficacy of therapeutic strategies for recurrent or refractory glioblastoma: a systematic review and network meta-analysis.Front Neurol2026https://conductscience.org/library/papers/42694176PubMed
42588736Reduced-Dose Regorafenib for Recurrent Glioblastoma: A Safety and Outcome Analysis.Cancers (Basel)2026https://conductscience.org/library/papers/42588736PubMed
42558850Glioblastoma stem cells as carriers of tumour memory: a strategy for personalised immunotherapy using tumour-infiltrating lymphocytes.Front Immunol2026https://conductscience.org/library/papers/42558850PubMed
42549406Targeting replication stress in glioblastoma: From genotoxic treatment and inhibitors of the DNA damage response to immunotherapy.Neurooncol Adv2026https://conductscience.org/library/papers/42549406PubMed
42524459C3G Downregulation Enhances Stemness in Glioblastoma Cells by Promoting PKM2 Upregulation.Int J Biol Sci2026https://conductscience.org/library/papers/42524459PubMed
42493681Salvage therapies for recurrent grade 4 IDH-wildtype glioma: a BRAIN Registry analysis of real-world treatment patterns.J Neurooncol2026https://conductscience.org/library/papers/42493681PubMed
42449033Hydrogel-Mediated Delivery of Drug Nanocarriers in the Oedematous Postoperative Brain.Pharm Res2026https://conductscience.org/library/papers/42449033PubMed
42368382Prognostic impact of circulating vitamin D and genetic variants in the vitamin D pathway in glioblastoma.Neurooncol Adv2026https://conductscience.org/library/papers/42368382PubMed
42251229Post-recurrence management of malignant glial brain tumors: therapeutic strategies, evidence and limitations, palliative care, terminal sedation, and end-of-life considerations.Clin Transl Oncol2026https://conductscience.org/library/papers/42251229PubMed
42238672Role of Bevacizumab in Multiple Glioblastomas: A Retrospective Single-Center Analysis.Neurosciences (Riyadh)2026https://conductscience.org/library/papers/42238672PubMed
42201434Precision reirradiation in recurrent CNS tumors integrating biology techniques and multimodal care.Discov Oncol2026https://conductscience.org/library/papers/42201434PubMed
42158948Network-driven prioritization and functional phenotyping nominate TTC23 as a biomarker-informed target in chlorpromazine repurposing for glioblastoma.Front Pharmacol2026https://conductscience.org/library/papers/42158948PubMed
42121885The Multifaceted Role of microRNA-10b (miR-10b) in Glioblastoma: From Oncogenic Driver to Therapeutic Target.Cells2026https://conductscience.org/library/papers/42121885PubMed
42101535Glioblastoma: epidemiology, molecular pathogenesis, diagnosis, management, and therapeutic resistance.Mol Biomed2026https://conductscience.org/library/papers/42101535PubMed

See all 104 cited byDownload CSV of cited by

Genes44

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
ANGPT1284PubTator's text mininghttps://conductscience.org/library/genes/284NCBI Gene
ANGPT2285PubTator's text mininghttps://conductscience.org/library/genes/285NCBI Gene
BCAR19564PubTator's text mininghttps://conductscience.org/library/genes/9564NCBI Gene
CARTPT9607PubTator's text mininghttps://conductscience.org/library/genes/9607NCBI Gene
CD27939PubTator's text mininghttps://conductscience.org/library/genes/939NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD27680381PubTator's text mininghttps://conductscience.org/library/genes/80381NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EPHB22048PubTator's text mininghttps://conductscience.org/library/genes/2048NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ERBB42066PubTator's text mininghttps://conductscience.org/library/genes/2066NCBI Gene
FGFR12260PubTator's text mininghttps://conductscience.org/library/genes/2260NCBI Gene
FGFR32261PubTator's text mininghttps://conductscience.org/library/genes/2261NCBI Gene
FLT12321PubTator's text mininghttps://conductscience.org/library/genes/2321NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene

See all 44 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37686553

GET https://conductscience.org/api/papers/v1/37686553/references?page=2